Landmark Report Refutes IDSA's Denial of Congenital Lyme

New peer-reviewed study challenges medical guidelines, calls for urgent action on Lyme in pregnancy

Apr. 13, 2026 at 10:18pm

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray-style image revealing the internal structures of a pregnant woman's abdomen, including the faint outline of a developing fetus and the intricate placenta, conceptually representing the complex medical issues surrounding Lyme disease in pregnancy.A groundbreaking scientific report challenges the medical establishment's denial of congenital Lyme, underscoring the urgent need for better understanding and care of pregnant women and their infants.Washington Today

A groundbreaking scientific report from the Banbury Conference at Cold Spring Harbor Laboratory is reshaping the medical understanding of Lyme disease in pregnancy. The peer-reviewed paper directly challenges a key assertion in the 2020 IDSA/AAN/ACR Lyme disease guidelines, concluding that the Lyme bacteria can cross the placenta and may contribute to serious adverse outcomes in pregnancy and infancy.

Why it matters

The Banbury findings underscore that Lyme disease in pregnancy is both a public health issue and a research priority. The report documents a wide spectrum of adverse outcomes associated with gestational Lyme, including miscarriage, stillbirth, preterm birth, neonatal death, and neurologic and cardiac abnormalities. It also highlights major challenges in diagnosing Lyme during pregnancy, raising critical questions about current treatment protocols and their effectiveness in preventing fetal transmission.

The details

The newly published paper, 'Perinatal transmission of Borrelia burgdorferi: advancing scientific and clinical understanding of Lyme disease in pregnancy,' concludes that the bacterium responsible for Lyme disease can cross the placenta. The authors emphasize that perinatal transmission is not a theoretical concern, but a documented biological phenomenon. They note that infection may occur even when the mother has no symptoms, with up to 40% of cases lacking the characteristic rash and serologic testing potentially being negative despite infection.

  • The Banbury Conference was held in June 2022 at Cold Spring Harbor Laboratory.
  • The resulting peer-reviewed paper was published in 2026.

The players

Borrelia burgdorferi

The bacterium responsible for Lyme disease.

IDSA/AAN/ACR

The Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology, which published the 2020 Lyme disease guidelines.

Bruce Fries

Founder and president of the Patient Centered Care Advocacy Group, based in the Washington, D.C. area.

Got photos? Submit your photos here. ›

What’s next

The Banbury Conference authors call for immediate and coordinated action, including longitudinal studies of pregnant women and exposed infants, improved diagnostic tools, development of clinical guidelines for pregnancy and neonatal care, and the establishment of registries and surveillance systems.

The takeaway

The Banbury report represents a watershed moment in Lyme disease research, fundamentally challenging outdated assumptions and calling into question current standards of care. By confirming that Lyme bacteria can cross the placenta and may harm developing fetuses, the findings demand a reassessment of clinical guidelines that continue to deny congenital infection.